Fundz

Curve Biosciences raises $40 million in a funding round led by Luma Group to advance its Whole-Body Intelligence platform for chronic disease monitoring.

PRIVATEOct 29, 2025

Amount Raised

$40 Million

Round Type

Funding Round

Mountain ViewOtherBiotechnology

Investors

LifeX VenturesMintaka VCNzvcMicah SpearFirst Spark VenturesTechas CapitalCivilization VenturesInciteLuma Group

Description

Curve Biosciences has successfully raised $40 million to enhance the clinical validation and commercialization of its Whole-Body Intelligence platform. The funding round was led by Luma Group with participation from multiple investors. This initiative aims to transform chronic disease monitoring through innovative biological insights. Further details about the platform will be shared in the coming months.

Quick answer

Curve Biosciences raised $40 Million in a Funding Round round, dated October 29, 2025. Investors: LifeX Ventures, Mintaka VC, Nzvc, Micah Spear, First Spark Ventures, Techas Capital, Civilization Ventures and Incite. Curve Biosciences is based in Mountain View, California, United States.

How much did Curve Biosciences raise?
Curve Biosciences raised $40 Million in a Funding Round round on October 29, 2025.
Who invested in Curve Biosciences?
LifeX Ventures, Mintaka VC, Nzvc, Micah Spear, First Spark Ventures, Techas Capital, Civilization Ventures and Incite are named as investors in this round.
What does Curve Biosciences do?
Curve Biosciences (“Curve”) is a company unlocking the potential of Chronic Epigenetics to bring precision to chronic disease care.
Where is Curve Biosciences based and how big is it?
Curve Biosciences is based in Mountain View, California, United States. Fundz records about 26 employees.
Who are the decision-makers at Curve Biosciences?
Fundz holds 1 contact at Curve Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Curve Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Elmentoz Research raised an undisclosed amount (Seed) on December 13, 2025.
  • Enveric Biosciences raised $107K on December 12, 2025.
  • Alphyn Biologics raised $25M (Series B) on December 12, 2025.
  • OXOS Medical raised $11M on December 12, 2025.
  • MyndTec raised $80K on December 12, 2025.
  • Glycologix raised $800K on December 12, 2025.

Who to call at Curve Biosciences, and when

A new round usually means Curve Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Curve Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Curve Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Curve Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Curve Biosciences

Location

901 Mariners Island Blvd, Suite 700

Mountain View, California, United States

About

Curve Biosciences (“Curve”) is a company unlocking the potential of Chronic Epigenetics to bring precision to chronic disease care. Curve creates products that target the biological changes in tissues that result in the development and progression of chronic diseases. Curve’s Whole Body Tissue Atlas (WBTA) uniquely allows the company to discover these precise changes with data from over 250,000 tissues across more than 1,000 clinical studies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Curve Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Curve Biosciences's next move

See what Strategic adds

Curve Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.